Xtx Topco LTD Tenaya Therapeutics, Inc. Transaction History

Xtx Topco LTD

$710 Million
Q1 2024

A detailed history of Xtx Topco LTD transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 30,876 shares of TNYA stock, worth $117,020. This represents 0.02% of its overall portfolio holdings.

Number of Shares

30,876

Holding current value

$117,020

% of portfolio

0.02%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 13, 2024	BUY	$2.88 - $6.8 $88,922 - $209,956	30,876 New	30,876 $161,000
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.65 $99,332 - $220,090	38,954 New	38,954 $99,000

Others Institutions Holding TNYA

# of Institutions

Shares Held

47.3M

Call Options Held

35.8K

Put Options Held

1.1K

Column Group LLC San Francisco, CA

9.4M
Shares

$35.6 Million
30.64% of portfolio
Casdin Capital, LLC New York, NY

6.73M
Shares

$25.5 Million
2.84% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$17.8 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.35M
Shares

$12.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.86M
Shares

$10.9 Million
0.0% of portfolio

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $157M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account